ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

In the Capital Market

previous year following increase in sales from Rs 29.89 crore to Rs 38.38 crore. These figures show a small decrease in profit margins, but net profit has short up from Rs 87 lakh to Rs 185 lakh. Equity dividend, maintained at 15 per cent on the enlarged capital, enjoys a thick earnings cover of as much as 16.18 times as against 14.05 times previously. The directors have thought it prudent to plough back a good part of the earnings for future expansion. During the year, the company invested over Rs 3 crore in capital assets for modernisation of plant and machinery and creation of additional facilities. A new high-speed ointment line was commissioned and film coating facilities were expanded in the Patalganga factory. The company has acquired from MIDC additional land admeasuring 9,300 sq metres, adjacent to this unit. The company's active and fruitful association with the national laboratories continues. In the current year, the company has acquired from CDRl, Lucknow, the technology for a new lipid lowering drug

To read the full text Login

Get instant access

New 3 Month Subscription
to Digital Archives at

₹826for India

$50for overseas users


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top